SNCA and Parkinson disease: In an AAV α-synuclein rat model of PD, animals that received unilateral AAV1/2 A53T α-synuclein showed a deficit in the use of their paw contralateral to the site of vector injection 3 weeks post-surgery, compared with empty vector controls.